Cover Image
市場調查報告書

全球家牛醫療市場(各產品,診斷藥,遺傳學,地區):成長,趨勢,預測

Global Cattle Health Market - Segmented by products, Cattle diagnostics, Cattle genetics, & Geography - Trends & Forecasts 2016-2021

出版商 Mordor Intelligence LLP 商品編碼 319381
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球家牛醫療市場(各產品,診斷藥,遺傳學,地區):成長,趨勢,預測 Global Cattle Health Market - Segmented by products, Cattle diagnostics, Cattle genetics, & Geography - Trends & Forecasts 2016-2021
出版日期: 2016年08月05日 內容資訊: 英文 190 Pages
簡介

全球家牛醫療市場在2014年為15億9,000萬美元規模。一般認為該市場到2019年前將以年複合成長率4.6%持續成長,並達到20億2,000萬美元的規模。

本報告提供全球家牛醫療市場現況與未來預測,提供您各市場區隔,各地區趨勢,並彙整主要的參與企業競爭環境與簡介等資料。

第1章 簡介

第2章 市場分析

  • 動物醫療產品
  • 動物醫療和人的醫療

第3章 市場趨勢

  • 推動市場的要素
    • 寵物飼主感情
    • 營養的改善
    • 消費者對食品安全性的注意力提升
    • 飼料的增產
    • 動物平原性傳染病及透過食物的傳染疾病
  • 阻礙市場的要素
    • 耕地和水的危機
    • 耕地的競爭激烈
    • 成本效益高的生產
  • 波特五力分析

第4章 市場區隔

  • 各產品
    • 疫苗
    • 寄生蟲驅除劑
    • 抗發炎藥
    • 醫療用食品添加物
    • 其他的醫藥品
  • 全球豬用診斷藥市場:各產品
  • 全球家牛用遺傳學市場
  • 各地區市場市場區隔
    • 北美
    • 歐洲
    • 亞太地區

第5章 競爭環境

  • 市場上主要企業
  • 合併·收購
  • 新產品上市
  • 協定,聯合,夥伴關係

第6章 企業簡介

  • Zoetis animal healthcare
  • Merck
  • Merial
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The global market for cattle health is currently estimated at USD 2,871 million for the year 2014 and is poised to reach USD 4,741 million by the end of 2020. The CAGR expected during this period of the forecast is 8.72%.

Global Cattle Health Market-Market Dynamics

Growing animal food product consumption is leading to an increase in demand for animal healthcare products and services. Cattle producers have long recognized the need for proper husbandry and stewardship, given the intensive animal husbandry model that currently houses a majority of cattle reared each year.

Drivers

Some of the key factors driving the market towards growth are:

  • Improved nutrition
  • Intensifying consumer focus on food safety
  • Greater livestock production rates
  • Increasing foodborne diseases
  • Growing beef production
  • Increasing demand for animal protein

Restraints

Scarcity of arable land and water, increased competition for cultivated land and cost effective production are the factors hindering the growth of the market.

Currently, North America leads the global market for cattle health, followed by Europe. However, developing regions like Asia-Pacific and Africa are expected to grow rapidly, forming new revenue pockets in the market. Countries such as India, China, and Japan are expected to be major contributors to this market over the next decade.

The global cattle health market is segmented by type of products (vaccines, parasiticides, anti-infectives, medicinal feed additives, and other pharmaceuticals), by diagnostics (Enzyme Linked Sorbent Assay (ELISA), Rapid Immuno migration (RIM), and Agar Gel Immunodiffusion (AGID), by molecular diagnostic tests (PCR, diagnostic imaging, ultrasound imaging, MRI), by genetics and by geography, the market is divided into North America, Asia-Pacific, Europe and Rest of the World.

Some of the key players in the market are:

  • Bayer Healthcare
  • Boehringer Ingelheim
  • Ceva Animal Health, Inc.
  • Elanco
  • Merck
  • Merial (Animal Health Division of Sanofi)
  • Virbac
  • Zoetis Animal Healthcare

What the Report Offers

  • Market definition for the global cattle health market along with identification of key drivers and restraints for the market.
  • Market analysis for the cattle health market, with region specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
  • Identification and analysis of the macro and micro factors that affect the cattle health market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. INTRODUCTION

  • 1.1. Market Definition
  • 1.2. Market Recent Trends

2. Market Analysis

  • 2.1. Market Animal Health Products
  • 2.2. Animal medicines vs. human Medicines

3. Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Improved Nutrition
    • 3.1.2. Intensifying consumer focus on food safety
    • 3.1.3. Greater Livestock production
    • 3.1.4. Increasing Zoonotic and Foodborne Diseases
  • 3.2. Market Constraints
    • 3.2.1. Scarcity of arable land and water
    • 3.2.2. Increased competition for cultivated land
    • 3.3.3. Cost-effective production
  • 3.3. Porter's Five Force Analysis
    • 3.3.1. Threat of New Entrant
    • 3.3.2. Internal Rivalry
    • 3.3.3. Buyer bargaining power
    • 3.3.4. Supplier bargaining power
    • 3.3.5. Threat of substitutes

4. Global Cattle Healthcare Market Segmentation

  • 4.1. Global Cattle healthcare market, By products
    • 4.1.1. Vaccines
    • 4.1.2. Parasiticides
    • 4.1.3. Anti-Infectives
    • 4.1.4. Medicinal Feed Additives
    • 4.1.5. Other Pharmaceuticals
  • 4.2. Global Cattle Diagnostic market, By products
    • 4.2.1. Introduction
      • 4.2.1.1. Immunodiagnostic Tests
      • 4.2.1.1.1. Enzyme-linked immunosorbent assay (ELISA)
      • 4.2.1.1.2. Rapid Immuno Migration (RIM‰a¢)
      • 4.2.1.1.3. Agar gel immunodiffusion (AGID)
      • 4.2.1.2. Molecular Diagnostic Tests
      • 4.2.1.2.1. Polymerase Chain Reaction (PCR)
      • 4.2.1.2.2. Diagnostic Imaging
      • 4.2.1.2.3. Ultrasound Imaging
      • 4.2.1.2.4. MRI Scanning
  • 4.3. Global Cattle Genetics Market
  • 4.4. Global Cattle Healthcare Market Segmentation, By Geography
    • 4.4.1. North America
      • 4.4.1.1. US
      • 4.4.1.2. Mexico
      • 4.4.1.3. Canada
    • 4.4.2. Europe
      • 4.4.2.1. France
      • 4.4.2.2. Italy
      • 4.4.2.3. Germany
      • 4.4.2.4. Spain
      • 4.4.2.5. Sweden
      • 4.4.2.6. Rest of Europe
    • 4.4.3. Asia-Pacific
      • 4.4.3.1. India
      • 4.4.3.2. China
      • 4.4.3.3. Japan
      • 4.4.3.4. Rest of Asia-Pacific

5. Competitive landscape

  • 5.1. Major players in the market
  • 5.2. Mergers and acquisitions
  • 5.3. New product launches
  • 5.4. Agreement, Collaborations, and Partnerships
  • 5.5. Recommendations for New market players
  • 5.6. Recommendations for Existing market players
  • 5.7. Market Share Analysis
  • 5.8. Value Chain Analysis

6. Company profiles

  • 6.1. Zoetis animal healthcare
  • 6.2. Merck
  • 6.3. Merial (Animal Health Division of Sanofi)
  • 6.4. Elanco
  • 6.5. Bayer healthcare
  • 6.6. Ceva Animal Health, Inc.
  • 6.7. Virbac
  • 6.8. Boehringer Ingelheim

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Sources
  • 7.3. Bibliography
  • 7.4. Disclaimer
Back to Top